AXIS
ActiveSummary
AXIS has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €79,980 and a net result of €7,983. Equity has been growing by about 6.6% per year since 2018. Its solvency ranks better than 76% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 26-05-2008 Normal situation
- Activity
- General medical practice NACE 86210and 1 other
- Establishment unit
- 2.171.795.653 2990 Wuustwezel, since 04-06-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 24-10-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €31,781
- ▲ 30.6%
- Turnover
- ≈ €98,000
- estimated
- Profit
- €7,983
- ▲ 13.5%
- Equity
- €79,980
- ▲ 11.1%
- Total assets
- €94,763
- ▲ 6.0%
Score breakdownlowers riskLiquidity: current ratio 3.92, cash €48,895Sector: Human health activities (NACE 86)Equity €79,980 (84.4% of total assets)Figures for financial year 2025 (filed on 31-07-2026)Show the evidence
Checked score
Score 2025
95
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 62% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
100=
equity 84.4% of total assets
Liquidity
98+13
short-term debt 13.4% · cash 51.6%
Profitability
79=
return on assets 8.4%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.92 (2.13 in 2024), above the usual 1.5. Short-term debt is 13.4% and cash 51.6% of total assets. 15.6% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 87% on liquidity, 25% on profitability and 54% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
1 day early
2023
5 days early
2022
on the day
2021
31 days early
2020
30 days late
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 3 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 31-07-2026 at the NBB all 18 filings
Turnover
≈ €98,000
Estimated: probably between €70,000 and €140,000
Total assets
€94,763▲ 6.0%
2024 · €89,367
Net result
€7,983▲ 13.5%
2024 · €7,031
Working capital
€37,041▲ 118%
2024 · €17,017
In the rankings
#6 oldest company in Wuustwezel, Health and social work sector
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is 11% higher than in 2024. It is a recovery after the fall in 2024.
Operating result€12,122
2025
Net result€7,983
2025
Total assets€94,763
2025
Equity€79,980
2025
Debt€14,783
2025
Working capital€37,041
2025
Return on assets (ROA)8.4%
2025
Solvency84.4%
2025
Current ratio3.92
2025
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€2,527-€8,716▲ 245%€9,112▲ 4.5%€1,364▼ 85.0%€8,360▲ 513%€12,905▲ 54.4%€10,960▼ 15.1%€12,122▲ 10.6%
Net result-€795-€5,196€5,217below the sector's middle half▲ 0.4%-€988below the sector's middle half€5,004below the sector's middle half€1,579below the sector's middle half▼ 68.5%€7,031below the sector's middle half▲ 345%€7,983below the sector's middle half▲ 13.5%
Equity€48,958-€54,154▲ 10.6%€59,372within the sector's middle half▲ 9.6%€58,384below the sector's middle half▼ 1.7%€63,388within the sector's middle half▲ 8.6%€64,966within the sector's middle half▲ 2.5%€71,997within the sector's middle half▲ 10.8%€79,980within the sector's middle half▲ 11.1%
Total assets€103,718-€91,071▼ 12.2%€84,157below the sector's middle half▼ 7.6%€86,251below the sector's middle half▲ 2.5%€82,157below the sector's middle half▼ 4.7%€85,813below the sector's middle half▲ 4.5%€89,367below the sector's middle half▲ 4.1%€94,763below the sector's middle half▲ 6.0%
Debt€54,760-€36,917▼ 32.6%€24,785▼ 32.9%€27,867▲ 12.4%€18,769▼ 32.6%€20,847▲ 11.1%€17,370▼ 16.7%€14,783▼ 14.9%
Working capital-€3,220-€1,632€10,948below the sector's middle half▲ 571%€11,491below the sector's middle half▲ 5.0%€17,246below the sector's middle half▲ 50.1%€22,235within the sector's middle half▲ 28.9%€17,017below the sector's middle half▼ 23.5%€37,041within the sector's middle half▲ 118%
Solvency47.2%-59.5%▲ 12.3pp70.5%within the sector's middle half▲ 11.1pp67.7%within the sector's middle half▼ 2.9pp77.2%within the sector's middle half▲ 9.5pp75.7%within the sector's middle half▼ 1.4pp80.6%within the sector's middle half▲ 4.9pp84.4%above the sector's middle half▲ 3.8pp
Current ratio0.88-1.09▲ 0.221.75within the sector's middle half▲ 0.661.83within the sector's middle half▲ 0.082.55within the sector's middle half▲ 0.722.74within the sector's middle half▲ 0.192.13within the sector's middle half▼ 0.613.92within the sector's middle half▲ 1.79
Return on assets (ROA)-0.8%-5.7%▲ 6.5pp6.2%within the sector's middle half▲ 0.5pp-1.1%below the sector's middle half▼ 7.3pp6.1%below the sector's middle half▲ 7.2pp1.8%below the sector's middle half▼ 4.3pp7.9%below the sector's middle half▲ 6.0pp8.4%below the sector's middle half▲ 0.6pp
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €94,763
Fixed assets
€45,027 ▼ 21.4%
Current assets
€49,736 ▲ 54.9%
Equity and liabilities €94,763
Equity
€79,980 ▲ 11.1%
Debt
€14,783 ▼ 14.9%
Debt's share of the balance-sheet total falls from 19.4% to 15.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€30,410▲
2024 · €22,561
Cash flow
€26,271▲
2024 · €18,632
Debt to equity
0.18▼
2024 · 0.24
ROE
10.0%▲
2024 · 9.8%
Interest coverage
63.44▲
2024 · 44.73
Debt ≤ 1 year
€12,695▼
2024 · €15,081
Debt > 1 year
€2,088▼
2024 · €2,288
Income taxes
€3,660▲
2024 · €3,425
Staff costs
€0▼
2024 · €175
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | €19,820 | €3,657 | €7,382 | €18,062 | €6,046 |
| Financial fixed assets | - | - | - | - | €0 |
| Depreciation and write-downs of the year | €17,593 | €10,741 | €10,344 | €11,601 | €18,288 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | - | - | €65 | €175 | €0 | ▼ 100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €25,861 | €15,046 | €15,566 | €17,593 | €10,741 | €10,344 | €11,601 | €18,288 | ▲ 57.6% |
| Other operating charges640/8 | - | - | - | €3,078 | €1,231 | €1,388 | €1,602 | €1,371 | ▼ 14.4% |
| Gross operating margin9900 | €29,069 | €25,193 | €25,973 | €22,034 | €20,332 | €24,701 | €24,338 | €31,781 | ▲ 30.6% |
| Operating profit (loss)9901 | €2,527 | €8,716 | €9,112 | €1,364 | €8,360 | €12,905 | €10,960 | €12,122 | ▲ 10.6% |
| Financial income75/76B | - | - | - | €1 | €61 | €2 | €0 | €0 | ▼ 100% |
| Recurring financial income75 | €0 | €7 | €7 | €1 | €61 | €2 | €0 | €0 | ▼ 100% |
| Financial charges65/66B | - | - | - | €797 | €342 | €9,645 | €504 | €479 | ▼ 5.0% |
| Recurring financial charges65 | €1,062 | €775 | €616 | €797 | €342 | €9,645 | €504 | €479 | ▼ 5.0% |
| Profit (loss) for the period before taxes9903 | €1,465 | €7,947 | €8,503 | €568 | €8,079 | €3,263 | €10,456 | €11,643 | ▲ 11.4% |
| Income taxes67/77 | €2,259 | €2,751 | €3,286 | €1,556 | €3,075 | €1,684 | €3,425 | €3,660 | ▲ 6.9% |
| Profit (loss) for the period9904 | -€795 | €5,196 | €5,217 | -€988 | €5,004 | €1,579 | €7,031 | €7,983 | ▲ 13.5% |
| Profit (loss) for the period to be appropriated9905 | -€795 | €5,196 | €5,217 | -€988 | €5,004 | €1,579 | €7,031 | €7,983 | ▲ 13.5% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €103,718 | €91,071 | €84,157 | €86,251 | €82,157 | €85,813 | €89,367 | €94,763 | ▲ 6.0% |
| Formation expenses20 | €0 | - | - | - | - | - | - | - | - |
| Fixed assets21/28 | €80,924 | €71,692 | €58,625 | €60,852 | €53,769 | €50,807 | €57,268 | €45,027 | ▼ 21.4% |
| Intangible fixed assets21 | €0 | - | - | - | - | - | - | - | - |
| Tangible fixed assets22/27 | €80,924 | €71,692 | €58,625 | €60,852 | €53,769 | €50,807 | €57,268 | €45,027 | ▼ 21.4% |
| Land and buildings22 | - | - | - | €53,824 | €50,979 | €43,745 | €36,511 | €29,277 | ▼ 19.8% |
| Plant, machinery and equipment23 | - | - | - | €7,028 | €2,790 | €7,062 | €5,409 | €9,432 | ▲ 74.4% |
| Furniture and vehicles24 | - | - | - | - | - | - | €15,348 | €6,317 | ▼ 58.8% |
| Leasing and similar rights25 | - | - | - | €0 | - | - | - | - | - |
| Financial fixed assets28 | €0 | - | - | - | - | - | - | - | - |
| Current assets29/58 | €22,793 | €19,379 | €25,532 | €25,398 | €28,388 | €35,006 | €32,098 | €49,736 | ▲ 54.9% |
| Amounts receivable after more than one year29 | - | - | - | €0 | - | - | - | - | - |
| Other amounts receivable291 | - | - | - | €0 | - | - | - | - | - |
| Stocks and contracts in progress3 | €0 | - | - | - | - | - | - | - | - |
| Amounts receivable within one year40/41 | €1,878 | €2,494 | €0 | €2,159 | €2,369 | €1,816 | €1,891 | €75 | ▼ 96.0% |
| Other amounts receivable41 | - | - | - | €2,159 | €2,369 | €1,816 | €1,891 | €75 | ▼ 96.0% |
| Current investments50/53 | €0 | - | - | - | - | - | - | - | - |
| Cash at bank and in hand54/58 | €13,735 | €13,867 | €21,046 | €18,829 | €20,178 | €31,875 | €27,895 | €48,895 | ▲ 75.3% |
| Deferred charges and accrued income490/1 | - | - | - | €4,410 | €5,841 | €1,315 | €2,312 | €767 | ▼ 66.8% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €103,718 | €91,071 | €84,157 | €86,251 | €82,157 | €85,813 | €89,367 | €94,763 | ▲ 6.0% |
| Equity10/15 | €48,958 | €54,154 | €59,372 | €58,384 | €63,388 | €64,966 | €71,997 | €79,980 | ▲ 11.1% |
| Contributions10/11 | €6,200 | €6,200 | - | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €42,758 | €47,954 | €53,172 | €52,184 | €57,188 | €58,766 | €65,797 | €73,780 | ▲ 12.1% |
| Non-distributable reserves130/1 | - | - | - | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | - | - | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | - | - | - | €50,324 | €55,328 | €56,906 | €63,937 | €71,920 | ▲ 12.5% |
| Profit (loss) carried forward14 | €0 | - | - | - | - | - | - | - | - |
| Provisions and deferred taxes16 | €0 | - | - | - | - | - | - | - | - |
| Amounts payable17/49 | €54,760 | €36,917 | €24,785 | €27,867 | €18,769 | €20,847 | €17,370 | €14,783 | ▼ 14.9% |
| Amounts payable after more than one year17 | €28,746 | €19,170 | €10,202 | €13,959 | €7,627 | €8,076 | €2,288 | €2,088 | ▼ 8.8% |
| Financial debts170/4 | - | - | - | €13,959 | €7,627 | €8,076 | €2,288 | €2,088 | ▼ 8.8% |
| Amounts payable within one year42/48 | €26,013 | €17,747 | €14,584 | €13,908 | €11,142 | €12,771 | €15,081 | €12,695 | ▼ 15.8% |
| Current portion of amounts payable after more than one year42 | - | - | - | €10,508 | €5,710 | €4,830 | €5,788 | €4,230 | ▼ 26.9% |
| Trade debts44 | €3,674 | €5,751 | €1,303 | €2,422 | €2,518 | €2,753 | €1,753 | €2,402 | ▲ 37.0% |
| Suppliers440/4 | - | - | - | €2,422 | €2,518 | €2,753 | €1,753 | €2,402 | ▲ 37.0% |
| Taxes, remuneration and social security45 | - | - | - | €0 | - | - | €1,061 | €160 | ▼ 84.9% |
| Taxes450/3 | - | - | - | €0 | - | - | €1,061 | €160 | ▼ 84.9% |
| Other amounts payable47/48 | - | - | - | €978 | €2,914 | €5,188 | €6,479 | €5,904 | ▼ 8.9% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€795 | €5,196 | €5,217 | -€988 | €5,004 | €1,579 | €7,031 | €7,983 | ▲ 13.5% |
| + Depreciation and write-downs630 | €25,861 | €15,046 | €15,566 | €17,593 | €10,741 | €10,344 | €11,601 | €18,288 | ▲ 57.6% |
| Operating cash flow (approximation) | €25,066 | €20,242 | €20,783 | €16,605 | €15,745 | €11,922 | €18,632 | €26,271 | ▲ 41.0% |
| Investment in fixed assets (approximation) | - | -€5,814 | -€2,499 | -€19,820 | -€3,657 | -€7,382 | -€18,062 | -€6,046 | ▲ 66.5% |
| Change in cash | - | €132 | €7,180 | -€2,217 | €1,348 | €11,697 | -€3,980 | €21,000 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 34,693 companies had the same profile as AXIS has now. Two years later, 0.7% had gone bankrupt and 95.3% were still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.7%
went bankrupt
3.9%
stopped otherwise
95.3%
was still going
That fits the bankruptcy probability of AXIS itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for AXIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 18 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 31-07-2026 | 2026-00366120 | |
| 31-12-2024 | micro format | 30-07-2025 | 2025-00331512 | |
| 31-12-2023 | micro format | 26-07-2024 | 2024-00288544 | |
| 31-12-2022 | micro format | 31-07-2023 | 2023-00295218 | |
| 31-12-2021 | micro format | 30-06-2022 | 2022-20112880 | |
| 31-12-2020 | micro format | 30-08-2021 | 2021-56100346 | |
| 31-12-2019 | micro format | 31-08-2020 | 2020-50600298 | |
| 31-12-2018 | abbreviated format | 29-08-2019 | 2019-63200017 | |
| 31-12-2017 | abbreviated format | 30-08-2018 | 2018-53200108 | |
| 31-12-2016 | abbreviated format | 24-08-2017 | 2017-46400392 |
Board & ownership
Directors
Directors
1 director, last change in 2023
HERMANS Erwin
Current
Director · appointed in the act of 27-12-2023 · earlier manager, until 27-12-2023 · term without a fixed end · listed in the 2025 annual accounts, filed on 31-07-2026
Owners and capital
Capital transactions
Capital over time
- 27-12-2023 Converted to available equity
Mandate history
1 person, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| HERMANS Erwin |
|
Articles of association
Board and representation
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Één of meer bestuurders, bezoldigd tenzij algemene vergadering bij benoeming anders beslist”
Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “1/100ste, alle effecten die niet door of krachtens de wet zijn verboden”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Procedure- en expertisekosten voor helft ten laste van overdrager en helft ten laste van kopers naar evenredigheid met verworven aantal als…”
Articles of association, deed of 27-12-2023 (in Dutch)
Network & group
AXIS shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of AXIS. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
31-07
micro format · on the deadline day
2025
31-12
Financial
Highest result from 2018 to 2025net €7,983 ▲13.5%
The net result of €7,983 is the highest of those years.
30-07
micro format · 1 day before the deadline
2024
26-07
micro format · 5 days before the deadline
2023
27-12
Gazette deed
Change of role: HERMANS Erwin, from manager to directorCapital conversion · Director discharge · Amendment of the articles9 points ▸
Gazette deed
Change of role: HERMANS Erwin, from manager to director
Capital conversion · Director discharge · Amendment of the articles9 points ▸
- General meeting, 15-12-2023
- Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, statuten aanpassen aan WVV” (deed in Dutch)
- Capital conversion, “beschikbaar voor uitkering” (deed in Dutch)
- Other provision, “inlichting comparanten over draagwijdte en verantwoordelijkheden, Instandhouding van het vermogen van de vennootschap,Uitkeringen aan de aandeelhouders en tanti…” (deed in Dutch)
- Director resignation, HERMANS Erwin (manager)
- Director discharge, HERMANS Erwin
- Director appointment, HERMANS Erwin (director)
- Amendment of the articles
- Other provision, “statutaire bepaling, alleen opschrift met ellipsis afgedrukt” (deed in Dutch)
31-07
micro format · on the deadline day
2022
31-12
Financial
Back to profitnet €5,004
The net result is €5,004, after one loss-making year.
30-06
micro format · 31 days before the deadline
2021
31-12
Financial
Weakest financial yearnet -€988
The net result drops to -€988, the lowest from 2018 to 2025. It recovers the following year.
30-08
micro format · 30 days late
2020
31-08
micro format · 31 days late
2019
31-12
Financial
Back to profitnet €5,196
The net result is €5,196, after one loss-making year.
Show earlier events
29-08
abbreviated format · 29 days late
2018
30-08
abbreviated format · 30 days late
2017
24-08
abbreviated format · 24 days late
2008
13-06
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
AXIS in Dutch
Enterprise number
0898.340.952
Legal form
Private limited company
Status
Active, normale toestand
Founded
26-05-2008
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 27-12-2023 (in Dutch)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaamse Gewest”
deed of 27-12-2023 (in Dutch)Registered office and establishments
Registered office
Bredabaan (Gooreind) 1055, 2990 Wuustwezel, Belgium
Establishment unit
AXIS, Bredabaan (Gooreind) 1055, 2990 Wuustwezel since 04-06-2008 · unit number 2.171.795.65385599 Other education
Activities
NACEBEL 202586210
General medical practice main activity
85599
Other education
Codes under NACEBEL 2008
86210
General medical practice main activity
85599
Other education
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 27-12-2023 (in Dutch)
“Uitbating van een praktijk voor Osteopathie en andere,aanvullende en/of alternatieve geneeswijzen zoals cranio-sacraal therapie,viscerale-en…”
10 activities
- Uitbating van een praktijk voor Osteopathie en andere,aanvullende en/of alternatieve geneeswijzen zoals cranio-sacraal therapie,viscerale-en structurele manuele therapieën voetreflexologie,traditionele Chinese geneeskunde,holistische massagetherapie met of zonder etherische oliën,magnetisme,mineralentherapie,voedingsadvies en correctie via vitaminen,mineralen,voedingssupplementen,bachbloesems,fytotherapie,orthomoleculaire geneeskunde,revalidatie in al zijn vormen gaande van fysiotherapie,fitness tot krachttraining met toestellen of trilplaat,klassieke geneeskunde.voor zover deze niet in strijd is met het gereglementeerd beroep van geneesheer
- Alle therapieën en begeleidingen waar er in de toekomst nog bijscholingenopleidingen worden voor gevolgd.
- Uitoefenen van een praktijk in de methode Gesret:specifieke behandelingswijze voor Immunitaire pathologieën zijnde astma,allergie,eczema,psoriasis.
- Het doceren,en het opvolgen van de behandelkwaliteit bij de opgeleide collega's van de bovengenoemde therapieën met daarbijhorend het zichzelf verder bekwamen in deze therapie door het volgen van-en organiseren van jaarlijkse bijscholingen in binnen-en buitenland.Het organiseren van postgraduate cursussen bij collega's thuis of op het adres van de maatschappelijke zetel in de daarvoor voorziene vergader archief-praktijkruimten.Het in die context ook regelmatig organiseren van multidisciplinaire meetings-lezingen,informatieavondenmiddagen op het adres van de maatschappelijke zetel ten behoeve van voorschrijvende artsen,collegae osteopaten,kinesisten,manueel therapeuten,of andere beroepen van de gezondheidszorg,inclusief het al dan niet gratis verstrekken van eigen gemaakt therapeutisch beeldmateriaal o.v.v.video,DVD,audio;hierbij gebruikmakend van de huidige modernste audiovisuele presentatiemogelijkheden.
- Het behandelen van mensen(ongeacht de leeftijd)met bovengenoemde therapieën ten huize van de maatschappelijke zetel,in de daarvoor ingerichte ruimten,of indien nodig bij de patiënten thuis of in een verzorgingsinstelling zo deze acte vereist is.Het mogelijk organiseren van transport voor mensen van hun domicilie naar de praktijk en vice versa indien nodig.
- Het behandelen van andere zoogdieren dan mensen via bovengenoemde therapieën met inzonderheid paarden en honden.
- Het cliënteel informeren omtrent bovengenoemde therapieën via het publiceren van flyers,informatiedocumenten onder welke vorm dan ook zonder in te druisen tegen de huidig geldende deontologische reglementeringen.
- Het tegen vergoeding ter beschikking stellen van de lokalen van de praktijk aan zelfstandig werkende collega's,ongeacht de discipline die ze beoefenen.
- Inkoop,verkoop of tussenpersoon(zowel groot als kleinhandel)in de verhandeling van voedingssupplementen,fytotherapie,etherische oliën,homeopathie,massageproducten,mineralen,wierook en andere geurproducten,boeken,muziek(CD-DVD),oorkaarsen,zalven,orthopedische kussens,decoratieartikelen,en alle ander therapeutisch begeleidingsmateriaal(paramedisch,medisch of niet).
- De uitbating van een workshop-atelier voor bloemsierkunst
Invoicing and payment
VAT number
BE 0898.340.952
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“Artikel 14 - Bijzondere volmachten … Artikel 15 - Strijdig belang … D. TOEZICHT Artikel 16 - Benoeming en bevoegdheid ... E. ALGEMENE…”
deed of 27-12-2023 (in Dutch)Sites & property
Location
Buildings and parcels at the address
Ground area
2,034 m²
Building footprint
248 m²
Building volume
1,292 m³
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11682G0473/02Y000 | Flanders | 2,034 m² | 1 · 248 m² | 8.3 m · 2 |